BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

Cytomegalovirus (CMV) continues to be a cause of substantial morbidity and death after
solid-organ transplantation. There are 3 major consequences of CMV infection: CMV …

OBJECTIVES: Cytomegalovirus (CMV) is a common opportunistic infection following renal
transplantation (RTx). It responds promptly to antiviral treatment. The mortality rate reaches …

Background. Antiviral prophylaxis has been shown to decrease the incidence of
cytomegalovirus (CMV) disease in organ transplant recipients, but whether CMV disease …

CYTOMEGALOVIRUS (CMV) INFECTION is frequently observed after solid organ
transplantation. After orthotopic liver transplantation (OLT) the incidence is reported to be as …

As the most prevalent pathogen among transplant patients, cytomegalovirus (CMV) affects
up to three‐quarters of all solid organ transplant recipients. While we have made great …

Background Despite advances in immunosuppressive therapy and post-transplantation
care, antiviral prevention, and therapy, cytomegalovirus (CMV) infection remains the most …

Liver and intestinal transplant recipients at the University of Miami receive an intensive
regimen of cytomegalovirus (CMV) prophylactic therapy consisting of a combination of CMV …

After allotransplantation, cytomegalovirus (CMV) may be transmitted from the donor organ,
giving rise to primary infection in a CMV negative recipient or reinfection in one who is CMV …

Long‐term prophylaxis against cytomegalovirus (CMV) started immediately after
transplantation in (D+/R−) poses a higher risk of late‐onset CMV disease. Delayed CMV …